Clinical trial
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have…
NCT00024102 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00024102 |
|---|---|
| Title | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer |
| Official title | A Randomized Trial of Adjuvant Chemotherapy With Standard Regimens, Cyclophosphamide, Methotrexate and Fluorouracil - (CMF) or Doxorubicin and Cyclophosphamide - (AC), Versus Capecitabine in Women 65 Years and Older With Node Positive or Node-Negative Breast Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Standard Treatment, capecitabine |
| Enrollment | 633 |
| Start date | Sep 1, 2001 |
| Primary completion | May 1, 2008 |
| Completion | Nov 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 12, 2016 |
| Countries | Canada, Peru, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: